 The patients randomized into SandRA group are instructed as usual. Regular doctor visits are scheduled at 3 months and at 6 months, when the SandRa monitoring ends. The following clinical data will be gathered. 1 ACR core data set at baseline, at 3 and 6 months, and at possible extra visits; 2 radiographs of the hands and the feet at baseline if not taken within 6 months; 3 antirheumatic medication and the possible causes of switches and changes over the 6 months 4 patient confidence VAS at each doctor visit; 5 quality of life SF-36 at baseline and at 6 months. Patient feedback of the system by a structured questionnaire is gathered at 6 months. 